This is an automated archive made by the Lemmit Bot.

The original was posted on /r/science by /u/YuriDeigin on 2024-09-23 17:37:52+00:00.

Original Title: New partial reprogramming result from Altos Labs: the Belmonte group reports a ~12% overall lifespan increase — equivalent to a ~38% increase in remaining lifespan after the start of therapy at 18 months — in normal mice via a Cdkn2a-OSK gene therapy: